Remove Development Remove Gene Editing Remove Licensing Remove Pharma Companies
article thumbnail

Europe: Where is the drug discovery innovation?

Drug Discovery World

In this article, DDW’s Diana Spencer highlights several prominent hotspots that are taking the lead on advancing European drug discovery and development. The oldest, still active pharmaceutical company worldwide, Merck, started life in 1668 in Darmstadt, Germany. The CDD will sponsor and manage KWF-supported trials.

Drugs 59
article thumbnail

The new pharma collaborations driving transformative research in oncology

pharmaphorum

As of 2018, there were over 1,100 cancer therapies in development, and as of 2020, 362 of them were cell and gene therapies. The industry is asking itself how to stay innovative, how to develop and bring to market higher quality therapies to patients – and how to do this faster and more efficiently.

Research 114
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Where is the drug discovery expertise happening in the UK?

Drug Discovery World

Cambridge boasts the world-renowned university alongside a biotech and pharma cluster situated throughout the city and its surrounding science parks, all of which helps attract top scientific talent.” At ELRIG’s Scottish Research and Drug Development Forum meeting, DDW’s Diana Spencer provided a snapshot of drug discovery in Scotland.

Drugs 75
article thumbnail

4 Life Sciences Trends for 2023

XTalks

In 2022 alone, the US regulator approved four new gene therapies, showing the high interest in getting these therapies to market. In 2023, a number of gene therapies are expected to get the FDA green light. The therapy, exagamglogene autotemcel (exa-cel), was granted a rolling review by the FDA. 4. Social Media Marketing.

article thumbnail

New horizon for cancer innovation

Drug Discovery World

RA: How can the integration of industry and academia help streamline drug development? . TH : Increasingly, large pharma companies need scale, agility and access to academic partnerships to succeed. HR : We want to streamline the drug discovery and development process for our industry partners. Tony Hickson.

HR 52
article thumbnail

Touchlight boosts DNA manufacturing capacity with latest expansion

Pharmaceutical Technology

The British company’s expanded facilities boasts of 11 suites, including two class B filling suites with class A filling cabinets, warehousing and quality control laboratory capability. One big pharma company has already given the seal of approval with a successful customer quality audit.

DNA 130